Short-Term Debt to Equity Ratio: NeurAxis, Inc. (NRXS)
NeurAxis, Inc. (NRXS) is protected by unique patents for electrical stimulators for children with gastrointestinal disorders, which, combined with strict FDA oversight, limits competition. This price action chart demonstrates a metric at 0.02 as the firm implements recyclable polymers and remote diagnostics. The company's operations focus on the eco-friendly disposal of electronics and strict energy conservation within its neuro-device assembly plants.
neuraxis.com (NRXS) - metric breakdowns and financial figures
- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- company liabilities and liquidity data:
- company profitability and valuation multiples indicators:
Analysis of all company metrics:NeurAxis, Inc NRXS
Fundamental asset selection requires an analysis of debt load to assess business resilience to external shocks. This indicator measures the proportion of liabilities with a maturity of over one year relative to equity, which allows the short-term leverage chart to evaluate the risk of NeurAxis, Inc. (NRXS) dependency on borrowings while implementing a pricing power strategy in the market for unique neurostimulation systems.
Analysis of competing companies
Short-Term Debt to Capital BIIB|NBIX - Current Liabilities to Capital|Regencell Bioscience - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital axsome.com AXSM|ACAD - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital XENE (Xenon Pharmaceuticals Inc.)|Viking Pharma (VKTX) - Short-Term Debt to Equity|Current Liabilities to Capital Supernus Corp (SUPN)|Short-Term Debt to Equity Catalyst Pharmaceuticals|Short-Term Debt to Capital Ratio DNLI (denalitherapeutics.com)|Short-Term Debt to Capital HRMY|BHVN - Current Liabilities to Capital|Amylyx - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Trevi Corp TRVI|PRAX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital AVXL (anavex.com)|CBLL: Short-Term Debt to Capital|Prothena Biosciences (PRTA) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio ALEC|Short-Term Debt to Capital Ratio ANNX (Annexon Biosciences Inc.)|Short-Term Debt to Capital OMER|Short-Term Debt to Capital Coefficient neurogene.com|Short-Term Debt to Equity AC Immune SA ACIU|Short-Term Debt to Capital Coefficient Voyager Therapeutics Inc (VYGR)|NMRA: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital SCLX (Scilex Holding Company, Inc.)|TVGN: Short-Term Debt to Capital|ACOG - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Cognition Therapeutics, Inc.|Short-Term Debt to Capital Ratio IKT (Inhibikase Therapeutics Inc)|Short-Term Debt to Capital SAVA|Short-Term Debt to Equity Ratio assertiotx.com ASRT|Coya Therapeutics - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Coefficient VistaGen Therapeutics, Inc. (VTGN)|OVID - Short-Term Debt to Equity|ABOS (Acumen Pharmaceuticals Inc.) - Short-Term Debt to Capital Ratio|CervoMed Inc (CRVO) - Short-Term Debt to Equity|Alterity Therapeutics Limited - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio CLNN|Short-Term Debt to Capital Ratio PEPG (PepGen Corp)|Short-Term Debt to Equity Jupiter Neurosciences (JUNS)|Short-Term Debt to Capital Coefficient Relmada Therapeutics Inc|Short-Term Debt to Equity Annovis Bio Corp ANVS|GRCE: Short-Term Debt to Capital Ratio|Firefly Neuroscience, Inc - Short-Term Debt to Capital|Current Liabilities to Capital Klotho Neurosciences Inc|NRSN (neurosense-tx.com) - Short-Term Debt to Equity Ratio|Reviva Pharmaceuticals Holdings Inc. (RVPH) - Short-Term Debt to Capital|Short-Term Debt to Equity MetaVia Inc.|HSDT: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Passage Bio, Inc. (PASG)|NEUP - Current Liabilities to Capital|Short-Term Debt to Equity Minerva Neurosciences, Inc. NERV|ATHA: Short-Term Debt to Capital Ratio|Addex Therapeutics, Ltd. - Short-Term Debt to Capital|Current Liabilities to Capital Alzamend Neuro, Inc.|CYCN (cyclerion.com) - Short-Term Debt to Equity Ratio|Protagenic Therapeutics, Inc. (PTIX) - Short-Term Debt to Capital|Short-Term Debt to Equity Pasithea Therapeutics Corp|CRGT: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ATXI|Short-Term Debt to Capital BrainStorm Cell Therapeutics Inc. (BCLI)|Cara Therapeutics, Inc. - Short-Term Debt to Equity Ratio|CHRO: Short-Term Debt to Capital Ratio|Eliem - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Intra-Cellular Therapies ITCI|Longboard Pharma (LBPH) - Short-Term Debt to Equity|MRNS - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio NKGN|NRBO: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital SAGE|Short-Term Debt to Capital Coefficient Synaptogenix Inc.|Short-Term Debt to Equity Trevena, Inc TRVN|VIGL: Short-Term Debt to Capital Ratio|Anew Medical, Inc. - Short-Term Debt to Capital|cerevel.com (CERE) - Short-Term Debt to Equity Ratio